Medication approval journey
hydroxyzine (Vistaril)
Approved for Anxiety and tension associated with psychoneurosis
Before changing anything
Low risk from stopping, but still worth planning
Withdrawal risk in this group is generally low, but dose changes are still worth discussing rather than improvising.
How long the trials actually ran
The gap between how long the trials ran and how long people actually take these medications is the single most important thing on this page. It is not evidence that longer use is unsafe or ineffective. It is evidence that longer use was not what got tested.
The approval, step by step
Step 1
What the approval was actually based on
Which studies did the FDA rely on, how long did they run, and who was in them?
Step 2
The approval
When was it approved, under what application, and by whose review?
- Approved
- May 31, 1956
- Application
- NDA010485
- Review
- STANDARD
Step 3
What was added after it was on the market
Which warnings arrived only after millions of people were already taking it?
Step 4
What independent research has found since
What has been learned by people who were not selling it?
Step 5
What still is not known
Which questions you might reasonably have has nobody answered yet?
Open hydroxyzine (Vistaril) in Resolv
The app has the full approval journey, the resources behind it, and people working through the same questions.
